This study is testing whether a drug called neflamapimod is safe and well-tolerated in people with dementia with Lewy bodies. Researchers will give 25 participants the drug twice daily for 24 weeks and monitor for side effects while also checking if it might help with thinking sk…
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC